| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 324186 | Journal of the American Academy of Child & Adolescent Psychiatry | 2014 | 15 Pages |
Abstract
Risperidone provided moderate but variable improvement in aggressive and other seriously disruptive child behaviors when added to PT and optimized stimulant treatment. Clinical trial registration information-Treatment of Severe Childhood Aggression (The TOSCA Study), URL: http://clinicaltrials.gov, unique identifier: NCT00796302.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Michael G. PhD, Oscar G. MD, MPH, Kenneth D. PhD, L. Eugene MEd, MD, Brooke S.G. PhD, Nora K. MD, E. Victoria MD, Xiaobai PhD, Heidi MEd, LPC, Jayne PhD, Eric M. PhD, Jennifer MA, Joyce PhD, Robert R. PhD, Srihari S. MD, MPH, Cristan A. PhD,
